News and Insights

Print this page

Search News & Insights

Matheson advises Royalty Pharma on $7.3 billion bid for Elan

AUTHOR(S): Tim Scanlon, George Brady, Fergus Bolster
DATE: 17.04.2013

Matheson is advising Royalty Pharma on its $7.3 billion cash offer for Elan Corporation plc, the Irish biotechnology company. The Matheson team is led by Tim Scanlon, George Brady and Fergus Bolster.

Royalty Pharma made an announcement of a firm intention to make the offer on 15 April 2013.  Elan is listed on NYSE and the Irish Stock Exchange.

Matheson continues to be selected as the law firm of choice on significant Irish corporate transactions. Matheson recently advised Eaton Corporation plc on its $11.8 billion acquisition of Cooper Industries. This was the largest single M&A transaction in Ireland during 2012 and was named 'Most Innovative Deal of the Year' at the Finance Dublin 2013 Awards.

The firm also recently advised on the sale of the country's biggest life and pensions provider Irish Life to Canada Life parent, Great-West Lifeco. The Financial Institutions Group at Matheson, led by partner Tim Scanlon, advised Ireland's Minister for Finance on the €1.3 billion sale, which has been described as a "historic transaction."

Matheson previously advised the Minister of Finance on the initial auction process for the sale of Irish Life in and its subsequent acquisition by the State from the Irish Life and Permanent Group in June 2012.

Matheson is the law firm of choice for international companies and financial institutions doing business in and through Ireland.


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)